Breaking News Instant updates and real-time market news.

DD

DuPont

$65.73

-16.8401 (-20.39%)

, HUM

Humana

$258.88

13.99 (5.71%)

09:55
06/03/19
06/03
09:55
06/03/19
09:55

Early notable gainers among liquid option names on June 3rd

Notable gainers among liquid option names this morning include DuPont de Nemours Inc (DD) $68.38 +4.33, Humana (HUM) $258.62 +13.68, Amgen (AMGN) $172.49 +5.75, Apache (APA) $26.84 +0.78, and United Rentals (URI) $113.33 +3.25.

DD

DuPont

$65.73

-16.8401 (-20.39%)

HUM

Humana

$258.88

13.99 (5.71%)

AMGN

Amgen

$172.42

5.71 (3.43%)

APA

Apache

$26.77

0.71 (2.72%)

URI

United Rentals

$113.90

3.805 (3.46%)

  • 03

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 25

    Jun

  • 13

    Nov

DD DuPont
$65.73

-16.8401 (-20.39%)

06/03/19
MSCO
06/03/19
INITIATION
Target $78
MSCO
Overweight
DuPont initiated with an Overweight at Morgan Stanley
Morgan Stanley analyst Vincent Andrews initiated "new" DuPont (DD) with an Overweight rating and $78 price target, stating that he sees value either if the stock is re-rated over time as a true multi-industry company, like 3M (MMM), or if the company were to pursue a separation of its four segments. While Andrews believes investors would prefer the latter, he thinks that nothing structural or strategic is likely to be announced before September 1, which would be the two-year anniversary of the DowDuPont merger, for tax reasons. He also acknowledges that a PFAS liability overhang may exist and, if one does, it could continue for some time.
HUM Humana
$258.88

13.99 (5.71%)

05/16/19
COWN
05/16/19
NO CHANGE
COWN
Move lower in managed care stocks appears overdone, says Cowen
Cowen analyst Charles Rhyee lowered his target multiple for the managed care group slightly from recent historical levels, but said he believes the recent weakness in the space on concerns around "Medicare for All," the rebate rule and the Texas ACA decision appears overdone. The discount for managed care stocks relative to the broader market has risen to a multi-year high, but he argues that underlying market fundamentals are stronger than in the pre-ACA era and Rhyee contends that there is "still plenty of growth left" in the managed care space, particularly in government-sponsored business. Stocks in the group include Anthem (ANTM), Cigna (CI), Centene (CNC), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
05/10/19
05/10/19
UPGRADE

Citi upgrades Anthem, Centene, UnitedHealth to Buy after 'extreme' selloff
Citi analyst Ralph Giacobbe upgraded Anthem (ANTM), Centene (CNC), and UnitedHealth (UNH) to Buy from Neutral while maintaining Buy ratings on Cigna (CI) and Humana (HUM). The magnitude of the selloff in managed care stocks on fears of Medicare for All has been "extreme and overdone," Giacobbe tells investors in a research note. The analyst sees favorable risk/rewards in the sector and does not subscribe to the view of a continued "overhang" and "uncertainty." Instead, Giacobbe expects a share recovery as "more realistic views prevail and investors become more numb to the low-likelihood headlines and political rhetoric of single payor."
05/07/19
SBSH
05/07/19
NO CHANGE
SBSH
Citi sees low likelihood of Centene walking from WellCare deal
Amid reports suggesting shareholders could challenge Centene's (CNC) acquisition of WellCare (WCG), and Humana (HUM) possibly being interested in a takeover of Centene if the WellCare deal was dropped, Citi analyst Ralph Giacobbe says he's be surprised to see the deal unravel. Further, he'd be equally surprised to see Humana come over the top for Centene after its Medicaid win in Florida and recent commentary citing optimism in its organic direction. That said, there is a scarcity of Medicaid assets, and Humana has discussed its interest in dual and other higher acuity Medicaid populations, Giacobbe tells investors in a research note. Nonetheless, the analyst ultimately sees a low likelihood of Centene walking from the WellCare deal.
05/02/19
FBCO
05/02/19
NO CHANGE
Target $315
FBCO
Outperform
Humana price target lowered to $315 from $352 at Credit Suisse
Credit Suisse analyst A.J. Rice lowered his price target for Humana to $315 from $352 following quarterly results given macro noise. The analyst reiterates an Outperform rating on the shares.
AMGN Amgen
$172.42

5.71 (3.43%)

05/20/19
FBCO
05/20/19
INITIATION
Target $208
FBCO
Outperform
Amgen initiated with an Outperform at Credit Suisse
Credit Suisse analyst Evan Seigerman initiated Amgen with an Outperform rating and a price target of $208, saying the stock is "attractive" relative to its peers because of its "underappreciated" biosimilars assets that may offset the expected revenue decline in its core business. The analyst is also positive on Amgen's promising pipeline that includes oncology and immunology assets along with its discounted valuation, noting that the stock is currently trading at 12.1-times expected forward earnings vs. 17.7-times for the S&P500 and 14.4-times or more for its major pharma peers.
05/22/19
SBSH
05/22/19
UPGRADE
SBSH
Buy
Amgen upgraded to Buy from Neutral at Citi
05/22/19
05/22/19
UPGRADE

Citi assumes coverage of large-cap biotech, upgrades Amgen and Gilead
Citi analyst Mohit Bansal assumed coverage of large-cap biotech stocks, assuming coverage with five Buy ratings -- Amgen (AMGN), Alexion Pharmaceuticals (ALXN), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), and BioMarin Pharmaceutical (BMRN) -- and two Neutral ratings -- Biogen (BIIB) and Regeneron Pharmaceuticals (REGN). Both Amgen and Gilead were upgraded to Buy from Neutral as part of the assumption of coverage. The analyst said he is "more optimistic" on the sector as a whole as he sees many biotechs going "back to basics" by investing in their internal pipelines and filling their pipelines with early stage assets. He suggests looking at large caps again, as many are returning to stability and growth. Bansal does not favor large M&A, suggesting discipline due to "realizing value with big M&As."
05/24/19
OPCO
05/24/19
NO CHANGE
Target $210
OPCO
Outperform
Amgen management comments 'encouraging,' says Oppenheimer
Oppenheimer analyst Jay Olson maintained an Outperform rating and $210 price target on Amgen after meeting with the company, saying he maintains his bullish stance. In a research note to investors, Olson says he is "encouraged" by Amgen's comments on the current status of Enbrel, Repatha potential with the lower list price, Aimovig launch and CGRP market dynamics, the oncology pipeline and capital allocation.
APA Apache
$26.77

0.71 (2.72%)

04/05/19
BMOC
04/05/19
NO CHANGE
Target $36
BMOC
Market Perform
Apache price target raised to $36 from $30 at BMO Capital
BMO Capital analyst Phillip Jungwirth raised his price target on Apache to $36 after traveling with its management this week, saying investor sentiment appears to have improved amid "Permian oil outperformance, Suriname opportunity, North Sea growth, and messaging around improving Alpine High margins." The analyst notes that the adjustment made to his model have taken his FY19 EPS outlook to $8.72 from $8.52 and his FY20 outlook to $9.02 from $8.80, even though he is keeping his Market Perform rating to reflect the company's "lower relative debt adjusted production growth."
03/06/19
MUFG
03/06/19
NO CHANGE
Target $47
MUFG
Overweight
Apache 2018 results, capital program 'significant positives', says MUFG
MUFG analyst Michael McAllister kept his Overweight rating and $47 price target on Apache, saying its 2018 results and commitment to return 50% of its free cash flow to shareholders should be considered "significant positives" to the investment narrative. The analyst adds that the company's 2019 capital outflows of $2.8B are "amply covered" by his cash flow forecast of $3.78B. With 40M share repurchase program "recast by the board", McAllister sees buybacks as the "first home" for Apache's free cash flows and believes that its capital program is "set up appropriately for the current price regime".
01/16/19
LEHM
01/16/19
INITIATION
Target $29
LEHM
Underweight
Apache initiated with an Underweight at Barclays
Barclays analyst Jeanine Wai started Apache with an Underweight rating and $29 price target. The analyst sees "below average" fundamentals metrics with limited upside to net asset value.
06/03/19
WOLF
06/03/19
UPGRADE
WOLF
Peer Perform
Apache upgraded to Peer Perform from Underperform at Wolfe Research
URI United Rentals
$113.90

3.805 (3.46%)

12/13/18
SBSH
12/13/18
NO CHANGE
SBSH
United Rentals added to the Citi Recommended List
Citi analyst Tobias Levkovich added United Rentals to the Citi Recommended List citing Tim Thein's Buy rating on the shares "due to a compelling positive fundamental outlook for the company and the US rental market into FY19."
12/14/18
LEHM
12/14/18
INITIATION
Target $130
LEHM
Equal Weight
United Rentals reinstated with an Equal Weight at Barclays
Barclays analyst Adam Seiden reinstated coverage of United Rentals with an Equal Weight rating and $130 price target. The analyst sees "slow, steady" low-to-mid single-digit growth for the rental industry in 2019, United Rentals included. He sees an even risk/reward at current share levels.
02/19/19
STPT
02/19/19
DOWNGRADE
STPT
Hold
United Rentals downgraded to Hold from Buy at Standpoint Research
04/01/19
OTRG
04/01/19
DOWNGRADE
OTRG
Mixed
United Rentals downgraded to Mixed from Positive at OTR Global
OTR Global downgraded United Rentals to Mixed from Positive following checks that indicate flattening utilization and growth.

TODAY'S FREE FLY STORIES

GPN

Global Payments

$164.14

1.2 (0.74%)

16:38
10/14/19
10/14
16:38
10/14/19
16:38
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 31

    Oct

  • 13

    Nov

APTS

Preferred Apartment

$14.41

0.075 (0.52%)

16:36
10/14/19
10/14
16:36
10/14/19
16:36
Hot Stocks
Preferred Apartment names Joel Murphy as CEO, effective January 1, 2020 »

Preferred Apartment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHI

Omega Healthcare

$43.05

0.65 (1.53%)

16:36
10/14/19
10/14
16:36
10/14/19
16:36
Hot Stocks
Omega Healthcare raises quarterly dividend to 67c from 66c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

RPAY

Repay Holdings

$13.21

-0.07 (-0.53%)

16:35
10/14/19
10/14
16:35
10/14/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Repay Holdings »

Repay Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

SQ

Square

$61.83

0.29 (0.47%)

16:34
10/14/19
10/14
16:34
10/14/19
16:34
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

FISV

Fiserv

$106.05

0.41 (0.39%)

, FDC

First Data

$0.00

(0.00%)

16:34
10/14/19
10/14
16:34
10/14/19
16:34
Initiation
Fiserv, First Data initiated  »

Fiserv initiated with a…

FISV

Fiserv

$106.05

0.41 (0.39%)

FDC

First Data

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 27

    Oct

LDOS

Leidos

$82.50

-0.66 (-0.79%)

16:31
10/14/19
10/14
16:31
10/14/19
16:31
Hot Stocks
Leidos awarded $926M TSA screening equipment contract »

Leidos was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 12

    Nov

RETA

Reata Pharmaceuticals

$100.37

4.57 (4.77%)

16:30
10/14/19
10/14
16:30
10/14/19
16:30
Hot Stocks
Breaking Hot Stocks news story on Reata Pharmaceuticals »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
10/14/19
10/14
16:30
10/14/19
16:30
Options
Preliminary option volume of 13.7M today »

Preliminary option volume…

FIS

FIS

$132.70

0.69 (0.52%)

16:29
10/14/19
10/14
16:29
10/14/19
16:29
Initiation
FIS initiated  »

FIS initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 19

    Nov

AKRX

Akorn

$3.81

-0.105 (-2.69%)

16:28
10/14/19
10/14
16:28
10/14/19
16:28
Hot Stocks
Akorn gets FDA approval for Betamethasone Dipropionate Lotion, augmented »

Akorn announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

EHTH

eHealth

$53.12

-2.86 (-5.11%)

16:27
10/14/19
10/14
16:27
10/14/19
16:27
Initiation
eHealth initiated  »

eHealth initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GPN

Global Payments

$164.14

1.2 (0.74%)

16:26
10/14/19
10/14
16:26
10/14/19
16:26
Initiation
Global Payments initiated  »

Global Payments initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 31

    Oct

  • 13

    Nov

SQ

Square

$61.83

0.29 (0.47%)

16:25
10/14/19
10/14
16:25
10/14/19
16:25
Initiation
Square initiated  »

Square initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

FISV

Fiserv

$106.05

0.41 (0.39%)

16:24
10/14/19
10/14
16:24
10/14/19
16:24
Initiation
Fiserv initiated  »

Fiserv initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 27

    Oct

FICO

Fair Isaac

$310.44

0.46 (0.15%)

16:23
10/14/19
10/14
16:23
10/14/19
16:23
Initiation
Fair Isaac initiated  »

Fair Isaac initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:22
10/14/19
10/14
16:22
10/14/19
16:22
General news
Empire State Mfg Survey General Business Conditions Index data reported »

October Empire State Mfg…

PD

PagerDuty

$26.45

0.27 (1.03%)

16:21
10/14/19
10/14
16:21
10/14/19
16:21
Initiation
PagerDuty initiated  »

PagerDuty initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RWT

Redwood Trust

$16.56

-0.1 (-0.60%)

16:20
10/14/19
10/14
16:20
10/14/19
16:20
Hot Stocks
Redwood Trust to acquire CoreVest for approximately $490M »

Redwood Trust announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
10/14/19
10/14
16:20
10/14/19
16:20
Options
Closing CBOE SPX and VIX Index summary for October 14th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$373.02

-1.88 (-0.50%)

, FB

Facebook

$183.29

-0.91 (-0.49%)

16:19
10/14/19
10/14
16:19
10/14/19
16:19
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stock futures fell in…

BA

Boeing

$373.02

-1.88 (-0.50%)

FB

Facebook

$183.29

-0.91 (-0.49%)

PE

Parsley Energy

$15.18

-1.8 (-10.60%)

JAG

Jagged Peak Energy

$6.72

-0.09 (-1.32%)

RVNC

Revance

$14.03

1.86 (15.28%)

HPE

HP Enterprise

$14.94

0.59 (4.11%)

SDC

SmileDirectClub

$9.71

-1.39 (-12.52%)

IPGP

IPG Photonics

$125.41

-10.71 (-7.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 14

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

  • 27

    Oct

  • 30

    Oct

  • 06

    Nov

  • 12

    Nov

ACC

American Campus

$48.27

-0.32 (-0.66%)

16:18
10/14/19
10/14
16:18
10/14/19
16:18
Earnings
American Campus raises FY19 FFOM to $2.40-$2.44 from $2.35-$2.45 »

Consensus $2.42. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Nov

BLMN

Bloomin' Brands

$18.14

-0.84 (-4.43%)

16:17
10/14/19
10/14
16:17
10/14/19
16:17
Downgrade
Bloomin' Brands rating change  »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

$19.92

0.12 (0.61%)

16:17
10/14/19
10/14
16:17
10/14/19
16:17
Hot Stocks
Associated Banc-Corp's First Staunton acquisition receives regulatory approval »

Associated Banc-Corp has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
10/14/19
10/14
16:17
10/14/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.